|
시장보고서
상품코드
2084820
근시용 및 노안용 점안제 시장 : 점안약별, 적응증별, 최종사용자별, 지역별Myopia And Presbyopia Eye Drops Market, By Eye Drops, By Indication, By End User, By Geography |
||||||
근시용 및 노안용 점안제 시장은 2026년에 16억 4,000만 달러 규모에 달할 것으로 추정되며, 2033년까지 26억 3,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 7.5%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 16억 4,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 7.50% | 예측 금액(2033년) | 26억 3,000만 달러 |
노안은 가까운 거리의 물체를 선명하게 보는 능력이 서서히 떨어지는 안과 질환입니다. 이는 노화에 따른 정상적인 현상입니다. 또한, 근시는 시력 저하를 유발하는 흔한 안과 질환이며, 교정되지 않은 근시는 전 세계적으로 원거리 시력 장애의 주요 원인 중 하나입니다. 일부 개별 연구에 따르면, 고도 근시 및 근시의 유병률은 지역이나 민족 집단에 따라 차이가 있는 것으로 나타났으며, 근시 유병률의 증가에 대해서는 여전히 불확실성이 남아 있습니다. 또한, 시장에 진출한 기업들은 소아 근시에 대한 인식을 높이기 위해 제휴 등 비유기적 전략에 주력하고 있으며, 이는 예측 기간 동안 시장 성장을 뒷받침할 것으로 기대됩니다. 예를 들어, 2020년 10월, Myopia Profile Pty Ltd와 에시롤 인터내셔널은 소아 근시 관리에 관한 기술, 임상 지식 및 실무 노하우를 안과 의료진에게 제공하기 위한 제휴 계약을 체결했습니다. 이번 제휴는 ‘근시’라고 불리는 근시의 폐해에 대한 대중의 인식을 높이는 데에도 기여할 것이며, 나아가 보호자들이 자녀에게 시력 검사를 받도록 유도하는 데에도 도움이 될 것입니다.
시장 역학
연구자들은 신기술을 활용해 근시 및 노안의 새로운 치료법을 개발하기 위한 연구 개발 활동에 주력하고 있으며, 이는 예측 기간 동안 전 세계 근시 및 노안용 점안제 시장의 성장을 견인할 것으로 예상됩니다. 예를 들어, 2019년 1월, 이스라엘 바르일란 대학교 나노기술·첨단소재연구소(BINA)는 근시나 노안 등 굴절 이상으로 인한 시력 문제를 교정하기 위한 ‘나노드롭’이라는 점안약을 개발했습니다. 이 안약은 합성 나노입자 용액으로 구성되어 있으며, 돼지의 각막을 사용하여 시험이 진행되었습니다. 연구진은 이 안약이 돼지의 근시와 노안이라는 두 가지 굴절 이상을 개선했다고 보고했습니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 근시용 및 노안용 점안제 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 근시용 및 노안용 점안제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 근시용 및 노안용 점안제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 근시용 및 노안용 점안제 시장 : 점안약별(2021-2033년)
제5장 근시용 및 노안용 점안제 시장 : 적응증별(2021-2033년)
제6장 근시용 및 노안용 점안제 시장 : 최종사용자별(2021-2033년)
제7장 근시용 및 노안용 점안제 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KSM 26.07.20Myopia And Presbyopia Eye Drops Market is estimated to be valued at USD 1.64 Bn in 2026 and is expected to reach USD 2.63 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.64 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.50% | 2033 Value Projection: | USD 2.63 Bn |
Presbyopia is an eye disorder, in which one's eyes gradually lose the ability to see things clearly up close distances. It is a normal part of aging. In addition, myopia is a common eye disorder that cause vision loss, and uncorrected myopia is amongst the leading cause of distance vision impairment worldwide. Several individual studies have shown variations in the prevalence of high myopia and myopia in regions and ethnic groups, and there continues to be uncertainty regarding increasing prevalence of myopia. Moreover, market players are focused on inorganic strategies such as partnerships, in order to increase awareness about childhood myopia which in turn is expected to boost the market growth over the forecast period. For instance, in October 2020, Myopia Profile Pty Ltd and Essilor International entered into a partnership agreement for empowering eye care practitioners with skills, clinical knowledge, and practice in managing childhood myopia. The partnership will also boost public awareness of the consequences of myopia, also called near sightedness, and in addition, this will also encourage parents to have their children's vision tested.
Market Dynamics
Researchers are focusing on research and development activities for the development of new treatment for myopia and presbyopia, by using new technologies, which is expected to drive growth of the global myopia & presbyopia eye drops market over the forecast period. For instance, in January 2019, Bar-Ilan University's Institute of Nanotechnology and Advanced Materials (BINA), Israel, developed eye drops called as 'nanodrops' for correcting the refractive-related vision problems such as myopia and presbyopia. The eye drops are made up of a synthetic nanoparticle solution and have been tested on pig's cornea. The researchers reported that the drops treated two kinds of refractive errors: myopia and presbyopia in pigs.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global myopia & presbyopia eye drops market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include Orasis Pharmaceuticals, AbbVie Inc. (Allergan), Novartis AG, OSRX Pharmaceuticals, LENZ Therapeutics, Visus Therapeutics, Ocuphire Pharma Inc., Eyenovia, Inc., Vyluma Inc., and Jawa Pharmaceuticals (India) Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global myopia & presbyopia eye drops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global myopia & presbyopia eye drops market
Market Segmentation
- By Eye Drops (Revenue, USD Bn, 2021-2033)
- Atropine Drops
- Pipeline Products
- CSF-1
- AGN - 190584
- Nyxol
- UNR844-Cl
- PRX-100
- MicroLine
- Others
- By Indication (Revenue, USD Bn, 2021-2033)
- Myopia
- Presbyopia
- By End User (Revenue, USD Bn, 2021-2033)
- Hospitals
- Ophthalmic Clinics
- Others
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Orasis Pharmaceuticals
- AbbVie Inc. (Allergan)
- Novartis AG
- OSRX Pharmaceuticals
- LENZ Therapeutics
- Visus Therapeutics
- Ocuphire Pharma Inc.
- Eyenovia, Inc.
- Vyluma Inc.
- Jawa Pharmaceuticals (India) Pvt. Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Eye Drops
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Myopia And Presbyopia Eye Drops Market, By Eye Drops, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Atropine Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Pipeline Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- CSF-1
- AGN-190584
- Nyxol
- UNR844-Cl
- PRX-100
- MicroLine
- Others
5. Myopia And Presbyopia Eye Drops Market, By Indication, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Myopia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Presbyopia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
6. Myopia And Presbyopia Eye Drops Market, By End User, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Ophthalmic Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
7. Myopia And Presbyopia Eye Drops Market, By Region, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Orasis Pharmaceuticals
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- AbbVie Inc. (Allergan)
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- OSRX Pharmaceuticals
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- LENZ Therapeutics
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Visus Therapeutics
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Ocuphire Pharma Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Eyenovia, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Vyluma Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Jawa Pharmaceuticals (India) Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Orasis Pharmaceuticals
- Analyst Views
9. Section
- References
- Research Methodology
- About Us
